Over the past two years since its establishment, the Institute of Translational Medical Science has focused on building a core translational research platform, initially establishing an innovative manufacturing base that integrates “innovation research, discipline development, and social service.” The institute has achieved groundbreaking results in scientific research, innovation platforms, talent cultivation, and the commercialization of research outcomes. The Institute of Translational Medical Science continues to enhance its technological innovation capabilities, leading to a continuous emergence of high-level achievements. In the past two years, it has published 13 high-quality SCI papers with an impact factor greater than 10. Since 2024, eight high-quality papers have been published (including accepted ones) with Zhejiang Shuren University as the first or corresponding author. The institute has been awarded the Provincial Key Laboratory Program for “Artificial Organs and Computational Medicine” and has hosted eight programs, including those funded by the National Natural Science Foundation and provincial research grants. It provides technical services such as analysis, testing, skills training, and scientific research cooperation for faculty and students within and outside the university, enhancing the level of high-end instrument platforms and social service capabilities.